TAG-72-Targeted {alpha}-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody

Conclusion: These results establish the potential for antibody-targeted α-radionuclide therapy for ovarian cancer, which may be generalized to α-radioimmunotherapy in other solid tumors.

Source: Journal of Nuclear Medicine - December 17, 2020 Category: Nuclear Medicine Authors: Minnix, M., Li, L., Yazaki, P. J., Miller, A. D., Chea, J., Poku, E., Liu, A., Wong, J. Y. C., Rockne, R. C., Colcher, D., Shively, J. E. Tags: Basic Source Type: research